GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
7S0C | 7S0C | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017 | |
7SOF | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
7SOF | 7SOF | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
7SXY | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7SXY | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7SY1 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
7SY1 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
7SY2 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7SY2 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7T9K | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 | |
7T9K | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 | |
7V7A | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation | |
7ACX | Q8KHI4 | H/L (SLPH/SLPL) complex from C. difficile (R7404 strain) | |
7ACX | Q9AEM2 | H/L (SLPH/SLPL) complex from C. difficile (R7404 strain) | |
7E9O | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) | |
7E9O | 7E9O | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) | |
7E9Q | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) | |
7E9Q | 7E9Q | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) | |
7LAW | Q9UNG2 | crystal structure of GITR complex with GITR-L | |
7LAW | Q9Y5U5 | crystal structure of GITR complex with GITR-L | |
7LX2 | 7LX2 | Cryo-EM structure of ConSOSL.UFO.664 (ConS) in complex with bNAb PGT122 | |
7LX3 | 7LX3 | Cryo-EM structure of EDC-crosslinked ConSOSL.UFO.664 (ConS-EDC) in complex with bNAb PGT122 | |
7LXM | 7LXM | Cryo-EM structure of ConM SOSIP.v7 (ConM) in complex with bNAb PGT122 | |
7LXN | 7LXN | Cryo-EM structure of EDC-crosslinked ConM SOSIP.v7 (ConM-EDC) in complex with bNAb PGT122 | |
7NYT | P62694 | Trichoderma reesei Cel7A E212Q mutant in complex with lactose. | |
7OC8 | P62694 | Trichoderma reesei Cel7A E212Q mutant in complex with pNPL | |
7Q1Z | P0DTC2 | Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein | |
7QPU | C1IPK2 | Botulinum neurotoxin A5 cell binding domain in complex with GM1b oligosaccharide | |
7R0Z | P0DTC2 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R0Z | Q9BYF1 | Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R11 | P0DTC2 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R11 | Q9BYF1 | Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R12 | P0DTC2 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R12 | Q9BYF1 | Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7R13 | P0DTC2 | Alpha Variant SARS-CoV-2 Spike in Closed conformation | |
7R14 | P0DTC2 | Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD | |
7R16 | P0DTC2 | Beta Variant SARS-CoV-2 Spike with 1 Erect RBD | |
7R17 | P0DTC2 | Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs | |
7R18 | P0DTC2 | Mink Variant SARS-CoV-2 Spike in Closed conformation | |
7R19 | P0DTC2 | Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs | |
7R1B | P0DTC2 | Mink Variant SARS-CoV-2 Spike with 1 Erect RBD | |
7S5P | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
7S5P | 7S5P | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
7S5Q | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
7S5Q | 7S5Q | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
7S5R | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 | |
7S5R | 7S5R | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 | |
7SAQ | Q9NUM4 | Cryo-EM structure of TMEM106B fibrils extracted from a FTLD-TDP patient, polymorph 1 | |
7SAR | Q9NUM4 | Cryo-EM structure of TMEM106B fibrils extracted from a FTLD-TDP patient, polymorph 2 | |
7SAS | Q9NUM4 | Cryo-EM structure of TMEM106B fibrils extracted from a FTLD-TDP patient, polymorph 3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024